Last edition
News about
Graph Secures USD 3 Million Seed Funding from Bessemer for AI-Driven Drug Safety
California-based Graph AI has announced its USD 3 Million Seed round, led by Bessemer Venture Partners. The investment will enable Graph to accelerate product innovation, expand its engineering team, and drive global market adoption.
Sanofi Names Montpellier Global Hub for Autoimmune Disease Research
Sanofi, in partnership with the Immun4Cure University Hospital Institute in Montpellier, has launched a Translational Centre of Excellence focused on developing treatments for autoimmune and inflammatory diseases. The centre aims to place patients at the core of R&D, spanning early research through advanced clinical trials.
Rubicon Research Listed on NSE
Mumbai-based pharmaceutical formulations company Rubicon Research Ltd has been officially listed on the National Stock Exchange (NSE).
Danish drugmaker Novo Nordisk has entered into a definitive asset purchase and license agreement with US-based Omeros Corporation for zaltenibart (formerly OMS906), a clinical-stage antibody therapy being developed for rare blood and kidney disorders.
AstraZeneca opens expanded manufacturing facility in Texas
AstraZeneca’s USD 445 million investment will support global manufacturing of Lokelma
Aragen Appoints Neeraj Garg as CEO to Bolster Discovery Leadership
In this role at Aragen, Neeraj Garg will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base.
Eli Lilly Reports Positive Phase 3 Topline Results for Oral GLP-1 Orforglipron in Type 2 Diabetes
Eli Lilly and Company has announced positive topline results from the Phase 3 ACHIEVE-2 and ACHIEVE-5 trials evaluating orforglipron for the treatment of type 2 diabetes.
India's Drugs & Pharmaceuticals Exports Continue Upward Trend in September 2025
India’s drugs and pharmaceuticals exports rose by 2.56 percent, reaching USD 2.62 billion in September 2025, up from USD 2.56 billion in the same month last year, according to the latest data from the Ministry of Commerce & Industry.
Ipca Laboratories Expands Global Footprint with New German Subsidiary
Ipca Laboratories has announced the incorporation of its wholly owned subsidiary, Ipca Pharmaceuticals GmbH, in the Federal Republic of Germany with an initial paid-up capital of Euro 25,000.
Syngene International Invests in Peptide Laboratory and Advanced Automation
Syngene International has set up a dedicated peptide laboratory equipped with advanced automation technologies to accelerate hit-to-lead timelines. The investment enhances the company’s integrated drug discovery and development capabilities, reinforcing its position as a leading partner for end-to-end research solutions.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy